Not every company is jumping onto the bandwagon and investing into weight loss drugs, however. One of the largest healthcare ...

Weight-loss supplements are rebranding as “GLP-1 boosters.” They’re nothing like Ozempic.

Telehealth sites prescribing GLP-1s online can get off the ground in a matter of days by “renting” the services of these ...

A review of the medical records of thousands of adolescents treated for obesity found that kids who received the GLP-1 ...

STAT reporters discuss investors' interest in autoimmune disease, GLP-1 supply issues, and big moments from #STATSummit.

The future of the weight loss market might not revolve around GLP-1 drugs.

A review of the recent evidence suggests that GLP-1 drugs, such as semaglutide, could protect brain health and cognitive ...

Those who took Ozempic or a similar drug had a 40% lower chance of overdosing on opioids and a 50% lower chance of getting ...

Now that the Mounjaro and Zepbound shortage is over, Eli Lilly is going after the cottage industry selling “compounded” ...

Researchers estimate that expanding access to weight-loss drugs could save over 50,000 lives annually, reducing obesity rates ...

Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) given to adolescents with obesity was associated with a one-third ...

Met With High Demand, the Dual-Product System is Clinically Shown to Increase GLP-1 by 140% on average to Balance Hunger ...